Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Test of vasocontriction properties for classification of topical steroid potency

Cassopeia Pharmaceuticals Pvt

Cassiopea S.p.A.

Cassopeia Pharmaceuticals Pvt patent portfolio — 12 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Chandigarh, IN HQ
2020 Founded
4 Employees
EMA registrant Type
Company details
Status
Public
HQ
Chandigarh, IN
Founded
2020
Employees
4
Programs
1
Drugs
6
Patents
12
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Cassopeia Pharmaceuticals Pvt patents

12 pharmaceutical patents indexed for Cassopeia Pharmaceuticals Pvt. 1 expire within 24 months.

Cassopeia Pharmaceuticals Pvt has 12 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

12 patents

Patent portfolio

  1. WO 2026087531

    FORMULATIONS DE CLASCOTÉRONE ET LEURS MÉTHODES D'UTILISATION

    Expires Wed Apr 25 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2026057588

    POLYTHÉRAPIE À BASE DE CLASCOTÉRONE ET DE MINOXIDIL POUR LE TRAITEMENT DE LA PERTE DES CHEVEUX

    Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2025172818

    POLYTHÉRAPIE À BASE DE PYRILUTAMIDE

    Expires Wed Aug 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2025125508

    COMBINAISONS DE CORTEXOLONE-17ΑLPHA-PROPIONATE POUR LE TRAITEMENT DE L'ACNÉ

    Expires Wed Jun 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. AR 132316

    TRATAMIENTO COMBINADO CON CLASCOTERONA Y MINOXIDIL

    Expires Tue Jun 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2025068281

    CORTÉXOLONE-17α-PROPIONATE POUR LE TRAITEMENT D'ÉRUPTIONS ACNÉIFORMES

    Expires Wed Mar 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. EP 4529925

    CORTEXOLON-17-ALPHA-PROPIONAT ZUR BEHANDLUNG VON AKNEIFORMEN ERUPTEN

    Expires Tue Mar 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 2018169113

    HIGH CONCENTRATION FORMULATION

    Expires Wed Jun 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 2016324873

    Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or its 9,11-Dehydroderivatives

    Expires Wed Nov 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. CA 2934118

    PROPIONATE DE CORTEXOLONE-17' DESTINE A ETRE UTILISE DANS LE TRAITEMENT DE LESIONS CUTANEES ET/OU DE TROUBLES DE LA PEAU ATROPHIQUE

    Expires Wed Jun 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. AU 2002328956

    17alfa, 21-dihydroxypregnene esters as antiandrogenic agents

    Expires Wed Aug 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. AU 2005207635

    Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds

    Expires Wed Jul 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Cassopeia Pharmaceuticals Pvt have?

12 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Cassopeia Pharmaceuticals Pvt patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.